IBDEI2U5 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,45229,0)
;;=C85.17^^170^2254^9
;;^UTILITY(U,$J,358.3,45229,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45229,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Spleen
;;^UTILITY(U,$J,358.3,45229,1,4,0)
;;=4^C85.17
;;^UTILITY(U,$J,358.3,45229,2)
;;=^5001708
;;^UTILITY(U,$J,358.3,45230,0)
;;=C85.10^^170^2254^10
;;^UTILITY(U,$J,358.3,45230,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45230,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Unspec Site
;;^UTILITY(U,$J,358.3,45230,1,4,0)
;;=4^C85.10
;;^UTILITY(U,$J,358.3,45230,2)
;;=^5001701
;;^UTILITY(U,$J,358.3,45231,0)
;;=L60.1^^170^2255^2
;;^UTILITY(U,$J,358.3,45231,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45231,1,3,0)
;;=3^Onycholysis
;;^UTILITY(U,$J,358.3,45231,1,4,0)
;;=4^L60.1
;;^UTILITY(U,$J,358.3,45231,2)
;;=^186837
;;^UTILITY(U,$J,358.3,45232,0)
;;=L60.2^^170^2255^1
;;^UTILITY(U,$J,358.3,45232,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45232,1,3,0)
;;=3^Onychogryphosis
;;^UTILITY(U,$J,358.3,45232,1,4,0)
;;=4^L60.2
;;^UTILITY(U,$J,358.3,45232,2)
;;=^5009235
;;^UTILITY(U,$J,358.3,45233,0)
;;=B35.1^^170^2255^3
;;^UTILITY(U,$J,358.3,45233,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45233,1,3,0)
;;=3^Onychomycosis
;;^UTILITY(U,$J,358.3,45233,1,4,0)
;;=4^B35.1
;;^UTILITY(U,$J,358.3,45233,2)
;;=^119748
;;^UTILITY(U,$J,358.3,45234,0)
;;=L60.3^^170^2255^4
;;^UTILITY(U,$J,358.3,45234,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45234,1,3,0)
;;=3^Onychorrexis/Onychodystrophy
;;^UTILITY(U,$J,358.3,45234,1,4,0)
;;=4^L60.3
;;^UTILITY(U,$J,358.3,45234,2)
;;=^5009236
;;^UTILITY(U,$J,358.3,45235,0)
;;=L50.8^^170^2256^4
;;^UTILITY(U,$J,358.3,45235,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45235,1,3,0)
;;=3^Urticaria,Other Spec
;;^UTILITY(U,$J,358.3,45235,1,4,0)
;;=4^L50.8
;;^UTILITY(U,$J,358.3,45235,2)
;;=^5009203
;;^UTILITY(U,$J,358.3,45236,0)
;;=L50.0^^170^2256^2
;;^UTILITY(U,$J,358.3,45236,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45236,1,3,0)
;;=3^Urticaria,Allergic
;;^UTILITY(U,$J,358.3,45236,1,4,0)
;;=4^L50.0
;;^UTILITY(U,$J,358.3,45236,2)
;;=^5009200
;;^UTILITY(U,$J,358.3,45237,0)
;;=L50.6^^170^2256^3
;;^UTILITY(U,$J,358.3,45237,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45237,1,3,0)
;;=3^Urticaria,Contact
;;^UTILITY(U,$J,358.3,45237,1,4,0)
;;=4^L50.6
;;^UTILITY(U,$J,358.3,45237,2)
;;=^5009202
;;^UTILITY(U,$J,358.3,45238,0)
;;=L50.2^^170^2256^1
;;^UTILITY(U,$J,358.3,45238,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45238,1,3,0)
;;=3^Urticaria d/t Cold/Heat
;;^UTILITY(U,$J,358.3,45238,1,4,0)
;;=4^L50.2
;;^UTILITY(U,$J,358.3,45238,2)
;;=^271938
;;^UTILITY(U,$J,358.3,45239,0)
;;=L56.3^^170^2256^5
;;^UTILITY(U,$J,358.3,45239,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45239,1,3,0)
;;=3^Urticaria,Solar
;;^UTILITY(U,$J,358.3,45239,1,4,0)
;;=4^L56.3
;;^UTILITY(U,$J,358.3,45239,2)
;;=^5009217
;;^UTILITY(U,$J,358.3,45240,0)
;;=B02.8^^170^2257^1
;;^UTILITY(U,$J,358.3,45240,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45240,1,3,0)
;;=3^Zoster w/ Other Complications
;;^UTILITY(U,$J,358.3,45240,1,4,0)
;;=4^B02.8
;;^UTILITY(U,$J,358.3,45240,2)
;;=^5000500
;;^UTILITY(U,$J,358.3,45241,0)
;;=B02.9^^170^2257^2
;;^UTILITY(U,$J,358.3,45241,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45241,1,3,0)
;;=3^Zoster w/o Complications
;;^UTILITY(U,$J,358.3,45241,1,4,0)
;;=4^B02.9
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2U5 3763 printed Nov 22, 2024@17:46:02 Page 2
IBDEI2U5 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,45229,0)
+2 ;;=C85.17^^170^2254^9
+3 ;;^UTILITY(U,$J,358.3,45229,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,45229,1,3,0)
+6 ;;=3^B-Cell Lymphoma,Unspec,Spleen
+7 ;;^UTILITY(U,$J,358.3,45229,1,4,0)
+8 ;;=4^C85.17
+9 ;;^UTILITY(U,$J,358.3,45229,2)
+10 ;;=^5001708
+11 ;;^UTILITY(U,$J,358.3,45230,0)
+12 ;;=C85.10^^170^2254^10
+13 ;;^UTILITY(U,$J,358.3,45230,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,45230,1,3,0)
+16 ;;=3^B-Cell Lymphoma,Unspec,Unspec Site
+17 ;;^UTILITY(U,$J,358.3,45230,1,4,0)
+18 ;;=4^C85.10
+19 ;;^UTILITY(U,$J,358.3,45230,2)
+20 ;;=^5001701
+21 ;;^UTILITY(U,$J,358.3,45231,0)
+22 ;;=L60.1^^170^2255^2
+23 ;;^UTILITY(U,$J,358.3,45231,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,45231,1,3,0)
+26 ;;=3^Onycholysis
+27 ;;^UTILITY(U,$J,358.3,45231,1,4,0)
+28 ;;=4^L60.1
+29 ;;^UTILITY(U,$J,358.3,45231,2)
+30 ;;=^186837
+31 ;;^UTILITY(U,$J,358.3,45232,0)
+32 ;;=L60.2^^170^2255^1
+33 ;;^UTILITY(U,$J,358.3,45232,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,45232,1,3,0)
+36 ;;=3^Onychogryphosis
+37 ;;^UTILITY(U,$J,358.3,45232,1,4,0)
+38 ;;=4^L60.2
+39 ;;^UTILITY(U,$J,358.3,45232,2)
+40 ;;=^5009235
+41 ;;^UTILITY(U,$J,358.3,45233,0)
+42 ;;=B35.1^^170^2255^3
+43 ;;^UTILITY(U,$J,358.3,45233,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,45233,1,3,0)
+46 ;;=3^Onychomycosis
+47 ;;^UTILITY(U,$J,358.3,45233,1,4,0)
+48 ;;=4^B35.1
+49 ;;^UTILITY(U,$J,358.3,45233,2)
+50 ;;=^119748
+51 ;;^UTILITY(U,$J,358.3,45234,0)
+52 ;;=L60.3^^170^2255^4
+53 ;;^UTILITY(U,$J,358.3,45234,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,45234,1,3,0)
+56 ;;=3^Onychorrexis/Onychodystrophy
+57 ;;^UTILITY(U,$J,358.3,45234,1,4,0)
+58 ;;=4^L60.3
+59 ;;^UTILITY(U,$J,358.3,45234,2)
+60 ;;=^5009236
+61 ;;^UTILITY(U,$J,358.3,45235,0)
+62 ;;=L50.8^^170^2256^4
+63 ;;^UTILITY(U,$J,358.3,45235,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,45235,1,3,0)
+66 ;;=3^Urticaria,Other Spec
+67 ;;^UTILITY(U,$J,358.3,45235,1,4,0)
+68 ;;=4^L50.8
+69 ;;^UTILITY(U,$J,358.3,45235,2)
+70 ;;=^5009203
+71 ;;^UTILITY(U,$J,358.3,45236,0)
+72 ;;=L50.0^^170^2256^2
+73 ;;^UTILITY(U,$J,358.3,45236,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,45236,1,3,0)
+76 ;;=3^Urticaria,Allergic
+77 ;;^UTILITY(U,$J,358.3,45236,1,4,0)
+78 ;;=4^L50.0
+79 ;;^UTILITY(U,$J,358.3,45236,2)
+80 ;;=^5009200
+81 ;;^UTILITY(U,$J,358.3,45237,0)
+82 ;;=L50.6^^170^2256^3
+83 ;;^UTILITY(U,$J,358.3,45237,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,45237,1,3,0)
+86 ;;=3^Urticaria,Contact
+87 ;;^UTILITY(U,$J,358.3,45237,1,4,0)
+88 ;;=4^L50.6
+89 ;;^UTILITY(U,$J,358.3,45237,2)
+90 ;;=^5009202
+91 ;;^UTILITY(U,$J,358.3,45238,0)
+92 ;;=L50.2^^170^2256^1
+93 ;;^UTILITY(U,$J,358.3,45238,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,45238,1,3,0)
+96 ;;=3^Urticaria d/t Cold/Heat
+97 ;;^UTILITY(U,$J,358.3,45238,1,4,0)
+98 ;;=4^L50.2
+99 ;;^UTILITY(U,$J,358.3,45238,2)
+100 ;;=^271938
+101 ;;^UTILITY(U,$J,358.3,45239,0)
+102 ;;=L56.3^^170^2256^5
+103 ;;^UTILITY(U,$J,358.3,45239,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,45239,1,3,0)
+106 ;;=3^Urticaria,Solar
+107 ;;^UTILITY(U,$J,358.3,45239,1,4,0)
+108 ;;=4^L56.3
+109 ;;^UTILITY(U,$J,358.3,45239,2)
+110 ;;=^5009217
+111 ;;^UTILITY(U,$J,358.3,45240,0)
+112 ;;=B02.8^^170^2257^1
+113 ;;^UTILITY(U,$J,358.3,45240,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,45240,1,3,0)
+116 ;;=3^Zoster w/ Other Complications
+117 ;;^UTILITY(U,$J,358.3,45240,1,4,0)
+118 ;;=4^B02.8
+119 ;;^UTILITY(U,$J,358.3,45240,2)
+120 ;;=^5000500
+121 ;;^UTILITY(U,$J,358.3,45241,0)
+122 ;;=B02.9^^170^2257^2
+123 ;;^UTILITY(U,$J,358.3,45241,1,0)
+124 ;;=^358.31IA^4^2
+125 ;;^UTILITY(U,$J,358.3,45241,1,3,0)
+126 ;;=3^Zoster w/o Complications
+127 ;;^UTILITY(U,$J,358.3,45241,1,4,0)
+128 ;;=4^B02.9
